Universität zu Köln

2016

Georgiev, P. G., Belada, D., Dakhil, S., Inhorn, L. F., Andorsky, D., Liberati, A. M., Beck, J. T., Quick, D., Patti, C., Sivcheva, L., Zaucha, J. M., Pettengell, R., Devries, T., Dean, J. P., Pavlyuk, M., Failloux, N. and Huebel, K. (2016). Phase 3 trial of pixantrone plus rituximab versus gemcitabine plus rituximab in treating relapsed/refractory transplant-ineligible aggressive non-Hodgkin's lymphoma. Ann. Oncol., 27. OXFORD: OXFORD UNIV PRESS. ISSN 1569-8041